Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE): Search
Now showing items 1-2 of 2
Communities or Collections matching your query
Items matching your query
Use of Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease Risk in Mild Cognitive Impairment and Subjective Cognitive Decline in Routine Clinical Care in Germany
(2020)
Background: The National Institute of Aging and Alzheimer's Association's diagnostic recommendations for preclinical Alzheimer's disease (AD) and mild cognitive impairment (MCI) define AD by pathological ...